21-45986696-GC-GCC
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001848.3(COL6A1):c.588+19dupC variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.03 in 1,544,256 control chromosomes in the GnomAD database, including 3,907 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.086 ( 1493 hom., cov: 31)
Exomes 𝑓: 0.024 ( 2414 hom. )
Consequence
COL6A1
NM_001848.3 intron
NM_001848.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.45
Publications
2 publications found
Genes affected
COL6A1 (HGNC:2211): (collagen type VI alpha 1 chain) The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008]
COL6A1 Gene-Disease associations (from GenCC):
- collagen 6-related myopathyInheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
- Bethlem myopathy 1AInheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P
- Ullrich congenital muscular dystrophy 1AInheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- Bethlem myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ullrich congenital muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 21-45986696-G-GC is Benign according to our data. Variant chr21-45986696-G-GC is described in ClinVar as Benign. ClinVar VariationId is 93880.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.25 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL6A1 | NM_001848.3 | c.588+19dupC | intron_variant | Intron 4 of 34 | ENST00000361866.8 | NP_001839.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL6A1 | ENST00000361866.8 | c.588+11_588+12insC | intron_variant | Intron 4 of 34 | 1 | NM_001848.3 | ENSP00000355180.3 |
Frequencies
GnomAD3 genomes AF: 0.0857 AC: 12998AN: 151632Hom.: 1492 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
12998
AN:
151632
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0478 AC: 7173AN: 150210 AF XY: 0.0483 show subpopulations
GnomAD2 exomes
AF:
AC:
7173
AN:
150210
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0239 AC: 33290AN: 1392506Hom.: 2414 Cov.: 34 AF XY: 0.0254 AC XY: 17462AN XY: 686934 show subpopulations
GnomAD4 exome
AF:
AC:
33290
AN:
1392506
Hom.:
Cov.:
34
AF XY:
AC XY:
17462
AN XY:
686934
show subpopulations
African (AFR)
AF:
AC:
8374
AN:
31432
American (AMR)
AF:
AC:
1037
AN:
35746
Ashkenazi Jewish (ASJ)
AF:
AC:
471
AN:
25172
East Asian (EAS)
AF:
AC:
6676
AN:
35692
South Asian (SAS)
AF:
AC:
7938
AN:
79144
European-Finnish (FIN)
AF:
AC:
154
AN:
43914
Middle Eastern (MID)
AF:
AC:
210
AN:
5228
European-Non Finnish (NFE)
AF:
AC:
6309
AN:
1078336
Other (OTH)
AF:
AC:
2121
AN:
57842
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.429
Heterozygous variant carriers
0
1734
3468
5202
6936
8670
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
544
1088
1632
2176
2720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0858 AC: 13015AN: 151750Hom.: 1493 Cov.: 31 AF XY: 0.0859 AC XY: 6372AN XY: 74164 show subpopulations
GnomAD4 genome
AF:
AC:
13015
AN:
151750
Hom.:
Cov.:
31
AF XY:
AC XY:
6372
AN XY:
74164
show subpopulations
African (AFR)
AF:
AC:
10469
AN:
41268
American (AMR)
AF:
AC:
654
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
57
AN:
3470
East Asian (EAS)
AF:
AC:
721
AN:
5072
South Asian (SAS)
AF:
AC:
479
AN:
4790
European-Finnish (FIN)
AF:
AC:
28
AN:
10616
Middle Eastern (MID)
AF:
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
AC:
481
AN:
67952
Other (OTH)
AF:
AC:
118
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
427
854
1280
1707
2134
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
345
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Sep 05, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
Mar 02, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Bethlem myopathy 1A Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Collagen 6-related myopathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.